Psychiatrists' treatment preferences for generalized anxiety disorder

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1077|33|1|hup.2643-hup.2643

ISSN： 0885-6222

Source： Human Psychopharmacology: Clinical And Experimental (Electronic), Vol.33, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Considerations in the Treatment of Generalized Anxiety Disorder

By Katzman Martin A.  

CNS Drugs, Vol. 23, Iss. 2, 2009-01 ,pp. : 103-120

Adis International

Access to resources Recommend Favorite

Non-Antidepressant Treatment of Generalized Anxiety Disorder

By  

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 86-96

Bentham Science Publishers

Access to resources Recommend Favorite

Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

By Carter Natalie J.   McCormack Paul L.  

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 523-541

Adis International

Access to resources Recommend Favorite

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Agomelatine in treating generalized anxiety disorder

By Demyttenaere Koen  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 857-864

Informa Healthcare

Access to resources Recommend Favorite